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1. Summary
Heat-shock protein (Hsp)10 is the co-chaperone for Hsp60 inside mitochondria,
but it also resides outside the organelle. Variations in its levels and intracellular dis-
tribution have been documented in pathological conditions, e.g. cancer and
chronic obstructive pulmonary disease (COPD). Here, we show that Hsp10 in
COPD undergoes changes at the molecular and subcellular levels in bronchial
cells from human specimens and derived cell lines, intact or subjected to stress
induced by cigarette smoke extract (CSE). Noteworthy findings are: (i) Hsp10
occurred in nuclei of epithelial and lamina propria cells of bronchial mucosa
from non-smokers and smokers; (ii) human bronchial epithelial (16HBE) and
lung fibroblast (HFL-1) cells, in vitro, showed Hsp10 in the nucleus, before and
after CSE exposure; (iii) CSE stimulation did not increase the levels of Hsp10
but did elicit qualitative changes as indicated by molecular weight and isoelectric
point shifts; and (iv) Hsp10 nuclear levels increased after CSE stimulation in HFL-
1, indicating cytosol to nucleus migration, and although Hsp10 did not bind DNA,
it bound a DNA-associated protein.
2. Introduction
The 10 kDa heat-shock protein (Hsp10) is classically considered a mitochondrial
co-chaperonin that interacts with Hsp60 to assist in the folding of other mito-
chondrial proteins [1]. Hsp10 does not contain a mitochondrial targeting
sequence, but its translocation to the organelle is mediated by its N-terminal
sequence that can form an amphipathic alpha helix, which enables it to cross
the mitochondrial membrane [2,3].
Hsp10 has been found in extra-mitochondrial sites such as secretory gran-
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appears in the maternal serum within 24 h after fertilization
in several mammalian species [6–10].
The nuclear gene encoding Hsp10 is HSPE1 (GeneID:
3336) and it is localized on 2q33.1, head-to-head on opposite
strands with the gene of Hsp60 (HSPD1) [11]. These genes are
controlled by a bidirectional promoter and the regulation of
the two genes was found to be simultaneous in eukaryotic
cells both under normal conditions and after stress [11].
A number of studies showed that the levels of Hsp10 are
increased, usually together with those of Hsp60, in various patho-
logic conditions such as colon cancer [12,13], post-ischaemic brain
[14] and myocardial ischaemia [15,16]. Also, Hsp10 levels were
found decreased in other pathological conditions, for example,
bronchial carcinogenesis [17]. We also found that Hsp10 and
Hsp60 decrease in bronchial dysplasia and adeno-squamous car-
cinoma [17,18], but increase in airways mucosa in smokers with
chronic obstructive pulmonary disease (COPD) [19].
COPD is a chronic inflammatory disease of central and per-
ipheral airways and lung parenchyma characterized by an
increased number of tissue lymphocytes, macrophages and
neutrophils [20]. Hsps have protective roles intracellularly but
are potentially pathogenetic when released outside cells, as
they can initiate/perpetuate inflammation [21]. In the lung,
intracellular Hsps have predominantly a cytoprotective effect
[22–24]. By contrast, extracellular Hsps may act as signal
molecules for the immune system, modulating the secretion
of proinflammatory cytokines [25–28]. In previous work, we
investigated in airways tissues the presence and levels of var-
ious Hsps, including Hsp10 and Hsp60, in relation to the
COPD severity [19]. We found that Hsp10 and Hsp60 levels
were increased in the bronchial epithelium of severe/very
severe COPD compared with control non-smokers; by contrast,
in lamina propria the number of Hsp10 positive cells was sig-
nificantly increased in all stages of stable COPD compared
with control smokers with normal lung function and non-
smoking subjects, while the number of Hsp60-positive cells
was significantly higher only in severe/very severe COPD com-
pared with control smokers with normal lung function. Hence,
we speculated that both molecules can be involved in maintain-
ing the inflammatory status. However, the different correlations
of Hsp60 and Hsp10 levels with smoking habits led us to
wonder about the effects of cigarette smoke on the expression
and subcellular localization of these proteins in bronchial
mucosa, i.e. in epithelial and lamina propria cells. We addressed
these issues pertaining to Hsp10 in the work reported here, by
means of in vivo and in vitro experiments.3. Material and methods
3.1. Recruitment of subjects, lung function tests,
fibreoptic bronchoscopy, collection and processing
of bronchial biopsies in patients with COPD
We selected and studied bronchial biopsies from 19 subjects with
normal lung function, nine current smokers (age¼ 64+8;
M : F ¼ 8 : 1) and 10 non-smokers (age¼ 65+9; M : F ¼ 9 : 1).
All subjects were Caucasians and were recruited from the Respir-
atory Medicine Unit of the ‘Fondazione Salvatore Maugeri’
(Veruno, Italy). The severity of the airflow obstruction wasstaged using current GOLD (Global Initiative for Chronic
Obstructive Lung Disease) criteria, as described [19].
Pulmonary function tests were performed as previously
described [20]. Pulmonary function tests included measure-
ments of FEV1 and FEV1/FVC under baseline conditions in
all the subjects examined (6200 Autobox Pulmonary Function
Laboratory; Sensormedics Corp., Yerba Linda, CA, USA).
Subjects were at the bronchoscopy suite at 08.30 h after
having fasted from midnight and were pre-treated with
atropine (0.6 mg IV) and midazolam (5–10 mg IV). Oxygen
(3 l min21) was administered via nasal prongs throughout the
procedure and oxygen saturation was monitored with a digital
oximeter. A fibreoptic bronchoscope (Olympus BF10 Key-
Med, Southend, UK) was passed through the nasal passages
into the trachea under local anaesthesia with lidocaine (4%) to
the upper airways and larynx. More lidocaine (2%) was sprayed
into the lower airways, and four bronchial biopsy specimens
were taken from segmental and sub-segmental airways of the
right lower and upper lobes using size 19 cupped forceps. Bron-
chial biopsies for immunohistochemistry were gently extracted
from the forceps and processed for light microscopy as pre-
viously described [20]. Two samples were embedded in Tissue
Tek II OCT (Miles Scientific, Naperville, IL, USA), frozen
within 15 min in isopentane pre-cooled in liquid nitrogen and
stored at –808C. The best frozen sample was then oriented and
6 mm thick cryostat sections were cut for immunohistochemical
light microscopy analysis and processed as described below.
3.2. Immunohistochemistry and scoring system
Two sections from each sample were stained applying immu-
nohistochemical methods with antibodies specific for Hsp10
(rabbit anti-Cpn10 polyclonal antibody, StressGen Bio-
technologies, Victoria BC, Canada, Cat. No. SPA-110,
dilution 1 : 300) and Hsp60 (mouse anti-Hsp60 monoclonal
antibody, Sigma, St. Louis, MO, Cat. No. H4149, dilution 1 :
300). Briefly, after blocking non-specific binding sites with
serum derived from the same animal species as that of the
secondary antibody, primary antibody was applied at the
set dilutions in Tris-buffered saline (0.15 M saline containing
0.05 M Tris–HCl at pH 7.6) and incubated 1 h at 238C in a
humid chamber. Antibody binding was demonstrated with
secondary antibodies, anti-rabbit (Vector, BA 1000) or anti-
mouse (Vector, BA 2000), followed by ABC kit AP AK5000,
Vectastain, and fast-red substrate (red colour). Slides were
included in each staining run with human tonsil or nasal
polyp as a positive control. For the negative control slides,
normal goat, mouse or rabbit non-specific immunoglobulins
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used
at the same protein concentration as the primary antibody.
Morphometric measurements were performed with a
light microscope (Leitz Biomed, Leica Cambridge, UK) con-
nected to a video recorder linked to a computerized image
system (Quantimet 500 Image Processing and Analysis
System, Software Qwin V0200B, Leica). Immunopositivity
was scored using a semi-quantitative approach. Three
independent observers (F.C., A.D.S. and B.B.) evaluated the
immunohistochemical results and quantified the percen-
tage of positive cells for each specimen both in epithelium
and lamina propria, down to 100 mm beneath the epithe-
lial basement membrane. Ten high-power fields were






on November 11, 2014Downloaded from 3.3. Preparation of cigarette smoke extract
Cigarette smoke extract (CSE) was obtained following proto-
cols standardized in our laboratory, using a Buchner flask
connected to a system acting as a vacuum-driven apparatus
[29]. Two cigarettes without filters were combusted and the
smoke was bubbled through 50 ml of serum-free Dulbecco’s
modified Eagle’s medium (DMEM). The obtained suspension
was then adjusted to pH 7.4 and filtered through a 0.22 mm
pore filter. This medium was defined 100% CSE and was
applied to cell cultures at different percentages (1, 2, 5 and
10%) within 20 min from preparation. Exposure of cells to
CSE was carried out with an incubation time of 24 h.
3.4. Cell cultures and in vitro model set-up
All experiments were conducted in triplicate. SV40-transformed
human bronchial epithelial (16HBE) and immortalized human
fetal lung fibroblast (HFL-1) cell lines were used to set up an
in vitro model in order to assess their behaviour after CSE
exposure. Both cell lines were cultured in 8-well chamber slides
and 25/75 cm2 tissue culture flasks (BD Falcon). Culture
medium was composed of DMEM containing 10% fetal bovine
serum (FBS), 100 U ml21 penicillin, 100 mg ml21 streptomycin,
0.25 mg ml21 amphotericin B and 2 mM L-glutamine (all from
Invitrogen, Milan, Italy). Cultures were maintained at 378C in a
humidified atmosphere of 5% CO2. Cells from passages 17–22
were used for the experiments. After reaching 70% of confluence,
cells were starved with serum-free DMEM, supplemented with
100 U ml21 penicillin, 100 mg ml21 streptomycin, 0.25 mg ml21
amphotericin B and 2 mM L-glutamine, for 24 h at 378C in a
humidified atmosphere 5% CO2. They were then treated with
various doses of CSE for different times, as outlined below.
After culturing, cells grown in chamber slides were
washed with phosphate-buffered saline (PBS) and fixed in
methanol for 20 min at 2208C. Air-dried slides were then
stored at 2208C until use (see ‘Immunocytochemistry and
scoring system’).
3.5. Cell viability assay
Cell viability after CSE exposure was evaluated by MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
assay (Sigma Aldrich). After CSE exposure for 24 h in 24-
well plates (Corning, Oneonta, NY, USA), culture medium
was replaced by MTT, previously diluted in phenol-red free
DMEM. After an incubation period of 3 h, the cell precipitate
was solubilized by using acidic absolute isopropanol (HCl
0.04 M). The amount of formazan was evaluated spectropho-
tometrically by reading A570, with background subtraction at
650 nm. Triton X-100 (1% v/v) was used as a positive control
for cytotoxicity. Triplicate assays were performed using cells
at different culture passages. Non-treated (NT) conditions
were used as controls in both cell lines.
3.6. Immunocytochemistry and scoring system
Immunocytochemistry (ICC) analyses were performed on
16HBE and HFL-1 cells cultured and treated in 8-well chamber
slides (BD Falcon), following previously published protocols
[30,31]. After culturing, cells were washed with PBS and fixed
in methanol for 20 min at 2208C. Air-dried slides were then
stored at 2208C until use. For the ICC procedure, the cellswere permeabilized with 0.1% Triton X-100 in PBS and then
washed with PBS. To block endogenous peroxidases, cells
were treated with 0.3% H2O2 in PBS and then with 1% FBS for
blocking non-specific antigens. Antibodies anti-Hsp10 (rabbit
polyclonal, StressGen) and anti-Hsp60 (mouse monoclonal,
clone LK1, Sigma Aldrich) were used at 1 : 300 dilution.
Antibody anti-prolyl 4-hydroxylase (clone 5B5, Dako, Copenha-
gen, Denmark) was used at 1 : 100 dilution as positive control for
the HFL-1 cells. Antibody anti-cytokeratin 8 (mouse mono-
clonal, Sigma) was used at 1 : 200 dilution as positive control
for the 16HBE cells. Negative controls were obtained subtracting
the primary antibody incubation step. The detection system
used was the LSAB (Labelled Streptavidin-Biotin)-2 kit
(Dako), an avidin–biotin complex system in which a biotiny-
lated secondary antibody reacts with peroxidase-conjugated
streptavidin molecules. The 3-amino-9-ethylcarbazole (AEC)þ
High Sensitivity Substrate Chromogen Ready-to-Use (Dako
Cytomation) was used as developer. Each passage was pre-
ceded by washes with PBS. The positive reaction was
observed using a light microscope (Leica DM 5000B).
Immunopositivity was scored using a semi-quantitative
approach [32,33]. Three independent observers (F.C., R.A.
and G.L.R.) separately evaluated the immunocytochemical
results in epithelium and lamina propria and determined the
percentage of positive cells for each specimen. Ten high-
power fields were examined in each culture slide and counting
of the cells was performed at 400 magnification.
3.7. Resin-embedding procedures and immunogold
analysis for Hsp10 subcellular localization
LR-White was used as resin to embed 16HBE and HFL-1 cells.
Cell fixation was carried out using a fixative solution (4% paraf-
ormaldehyde, 1 PBS pH 7.4, 0.2% glutaraldehyde). After
washing with 1 PBS pH 7.4, the cells were dehydrated by suc-
cessive passages through increasing percentages of ethanol
solutions (30, 50, 70 and 80%). Then cells were embedded in
LR-White resin. Ultrathin sections of 70–100 nm were layered
on gold mesh grids. To block endogenous peroxidases, the
grids with sections were incubated with 0.3% H2O2. To block
non-specific antigens, 3% bovine serum albumin (BSA; Aurion
BSA-c, Electron Microscope Sciences, Hatfield, PA, USA) in
1 PBS pH 7.6 was used. For immunolocalization, ultrathin sec-
tion-containing mesh grids were incubated with anti-Hsp10
(rabbit polyclonal, StressGen) and anti-Hsp60 (mouse mono-
clonal, clone LK1, Sigma Aldrich) at 1 : 30 dilution, and then
with 10 nm colloidal gold particle-coupled anti-rabbit (10 nm
gold-labelled goat anti-rabbit IgG (H þ L) RPN421V, Amer-
sham Biosciences, Milan, Italy) or anti-mouse (Electron
Microscope Sciences) secondary antibodies at 1 : 30 dilution.
A fixation step with 2% glutaraldehyde preceded the contrast
procedure. The latter was carried out incubating grids with 1%
(w/v) uranyl acetate in dark, methanol, and then with Reynold’s
lead citrate solution in dark. After washing with deionized water
and drying, sections were examined with a transmission electron
microscope (JEM-1220, JEOL, Milan, Italy).
3.8. One-dimensional protein electrophoresis (SDS-
PAGE) and western blotting
Measurements were carried out of the variations of Hsp10 and
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trol conditions, using one-dimensional (1D) sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). A
fixed amount of total and sub-fractionated proteins (30 mg for
each sample) was loaded with sample buffer (0.5 M Tris–
HCl pH 6.8, 10% SDS, 10% glycerol, bromophenol blue,
0.2 M dithioerythritol (DTE)) and applied to a 12% SDS-
PAGE gel. Gel run was performed for 2 h at 238C. For the
subsequent western blotting, gels obtained from 1D electro-
phoresis were incubated in transfer buffer (190 mM glycine,
25 mM Tris, 20% methanol) for 30 min and then blotted on
polyvinylidene di-fluoride (PVDF) membrane (Hybond-P,
GE Healthcare, Milan, Italy). After antigen blocking for 1 h
with 3% BSA in 0.05% Tween-20 Tris-buffered saline (T-TBS)
pH 7.6, membranes were exposed overnight at 48C to specific
primary antibodies: anti-Hsp10 (rabbit polyclonal, StressGen)
at 1 : 2000 dilution, or anti-Hsp60 (mouse monoclonal, clone
LK1, Sigma Aldrich) at 1 : 1000 dilution; anti-b-actin (mouse
monoclonal, clone AC-74, Sigma Aldrich) at 1 : 2000 dilution
and anti-LDH (rabbit monoclonal, clone EP1563Y Epitomics)
at 1 : 2500 dilution were used as cytoplasmic control anti-
bodies and anti-lamin A (rabbit polyclonal, Sigma Aldrich)
at 1 : 5000 dilution was used as nuclear control antibody.
All antibodies were diluted in antibody buffer (1% BSA,
0.05% T-TBS). Membranes were then incubated with specific
horseradish peroxidase (HRP)-labelled secondary antibodies,
anti-rabbit (1 : 50 000 dilution) and anti-mouse (1 : 10 000
dilution; both from GE Healthcare), for 1 h. They were exposed
to chemo-luminescent substrate (Immobilon, Millipore, Biller-
ica, MA, USA) for 5 min and then developed in a dark room
on chemiluminescence films (Hyperfilm, GE Healthcare).3.9. Two-dimensional protein electrophoresis
(SDS-PAGE) and western blotting
Total proteins from NT and 5% CSE-treated 16HBE and HFL-1
cells were separated according to two independent properties in
two steps, using two-dimensional (2D) electrophoresis. In the
first-dimension run, isoelectric focusing (IEF), proteins were
separated according to their isoelectric point (pI) on immobi-
lized pH gradient (IPG) strips (Immobiline DryStrip gels, GE
Healthcare). In the second-dimension run, SDS-PAGE separ-
ated the proteins according to their molecular weight. For this
study, we used two 7-cm IPG strips with nonlinear pH gradient:
4–7 for Hsp60 and 6–11 for Hsp10 (GE Healthcare) and a 10%
2D gel for SDS-PAGE. Prior to IEF, each IPG strip for each con-
dition was previously rehydrated with rehydration solution
(8 M urea, 2% w/v CHAPS, 0.5% v/v IPG buffer, 0.002% bro-
mophenol blue (1% stock solution), double-distilled water, to
which was added the reducing agent dithioerythritol prior
to use). Samples were diluted in this solution and allowed to
enter IPG strips for 1 h at 238C. The first-dimension run
included six steps at various voltages (‘step and hold’ or ‘gradi-
ent’) at different times: (i) hold at 30 V for 720 min, (ii) hold at
100 V for 15 min, (iii) gradient 100 V to 300 V for 30 min,
(iv) hold at 300 V for 20 min, (v) gradient 300 V to 3000 V
60 min and (vi) hold at 3000 V for 105 min.
After IEF, protein-separated IPG strips were equilibrated
with SDS equilibration solution (6 M urea, 75 mM Tris–HCl
pH 6.8, 29.3% glycerol, 2% SDS, double-distilled water), pre-
pared in order to obtain two buffers, one containing DTE as
reducing agent (Buffer A) and one containing iodoacetamide(which alkylates reduced sulfurs) and bromophenol blue
(Buffer B). Equilibrated IPG strips were used for the
second-dimension run, which comprised two subsequent
steps at different constant currents and different times:
10 mA gel21 for 10 min; and 20 mA gel21 for 120 min.
For both first- and second-dimension runs the Zoom Dual
Power adapter (Life Technologies, Milan, Italy) was used.
3.10. Image acquisition and data analysis
Two-dimensional gels were stained with ammoniacal silver
nitrate as previously described [34]. Silver-stained gels were
imaged with a ChemiDoc MP system (Bio-Rad, Milan, Italy).
Gel analysis was then performed using IMAGE MASTER PLATINUM
software (GE Healthcare). As internal standard for gel cali-
bration, we used an array of features of the cell lysate,
whose pI and relative molecular mass (Mr) were formerly
estimated by interpolation with serum proteins that had
co-migrated with the whole cell lysate. Further identifications
of spots of interest were made by western blotting of 2D gels.
3.11. Coomassie blue staining, nano-high performance
liquid chromatography and electrospray mass
spectrometry
Proteins were stained with Coomassie Brilliant Blue G-250
stain (SimplyBlue Safestain, Invitrogen). Stained gels were
digitalized, and image analysis was performed using IMAGE
MASTER PLATINUM software. Spots from 2DE maps of biological
interest were carefully excised from the gel and subjected to in-
gel trypsin digestion according to published procedures [35]
with minor modications. Protein identification was performed
as previously reported [36] through a nanoHPLC (Proxeon,
Bruker Daltonics, Macerata, Italy) and MS/MS ion trap
(Amazon ETD, Bruker Daltonics) system. Instrument settings
were consistent with our previous studies [37].
The spray capillary was a fused silica capillary, 0.090 mm
o.d., 0.020 mm i.d. For all experiments, a sample volume of
15 ml was loaded by the autosampler onto a homemade 2 cm
fused silica precolumn (100 mm i.d.; 375 mm o.d.; Reprosil C18-
AQ, 5 mm, Dr. Maisch, Ammerbuch-Entringen, Germany).
Sequential elution of peptides was accomplished using a flow
rate of 300 nl min21 and a linear gradient from Solution A (2%
acetonitrile; 0.1% formic acid) to 50% of solution B (98% aceto-
nitrile; 0.1% formic acid) in 40 min over the precolumn in-line
with a homemade 15 cm resolving column (75 mm i.d.; 375 mm
o.d.; Reprosil C18-AQ, 3 mm, Dr. Maisch). The acquisition par-
ameters for the instrument were as follows: dry gas
temperature, 2208C; dry gas, 4.0 l min21; nebulizer gas, 10 psi;
electrospray voltage, 4000 V; high-voltage end-plate offset,
2200 V; capillary exit, 140 V; trap drive, 63.2; funnel 1
in, 100 V, out 35 V and funnel 2 in, 12 V, out 10 V; ICC target,
200 000; maximum accumulation time, 50 ms. The sample was
measured with the ‘Enhanced Resolution Mode’ at 8100 m/z
per second (which allows mono-isotopic resolution up to four
charge stages) polarity positive, scan range from m/z 300 to
1500, five spectra averaged and rolling average of 1. The
‘Smart Decomposition’ was set to ‘auto’.
Acquired CID (collision-induced dissociation) spectra were
processed in DATAANALYSIS v. 4.0, and deconvoluted spectra
were further analysed with BIOTOOLS v. 3.2 (Bruker Daltonics)
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were adopted for database searches with MASCOT search pro-
gram: NCBInr database (release date 10 March 2013; 247 209
sequences); taxonomy ¼ Homo sapiens; peptide mass tolerance
of +0.3 Da; fragment mass tolerance of +0.3 for CID ions;
enzyme specificity, trypsin with two missed cleavages con-
sidered; fixed modifications: carbamidomethyl (C); variable
modifications: oxidation (M).
3.12. Total and sub-fractionated proteins extraction
The 16HBE and HFL-1 cells were collected after treatment and
were lysed with lysis buffer (20 mM Tris–HCl pH 7.5, 1% Non-
idet P-40, 50 mM NaCl, 1 Proteases Inhibitor) in order to
obtain total proteins. In parallel, separate nuclear and cyto-
plasmic fractions were obtained using Nuclear Extract Kit
(Active Motif, Carlsbad, CA, USA), following the manufac-
turer’s instructions. Protein concentration was determined
spectrophotometrically, using the DC Protein Assay kit
(Bio-Rad), following the manufacturer’s instructions.
3.13. Chromatin extracts and western blotting
Chromatin protein extracts derived from 16HBE and HFL-1 cells
were prepared according to previously published protocols [38].
16HBE and HFL-1 cells were collected and each cell line was split
in two tubes with or without 2% formaldehyde in 100 ml of 0.5 
M buffer (10 mM HEPES–KOH (pH 7.6), 25 mM KCl, 5 mM
MgCl2, 5% glycerol), 1 mM dithiothreitol (DTT) and 1 mM
phenyl methyl sulfonyl fluoride (PMSF) and incubated for
15 min at 238C. Both cross-linked and not cross-linked samples
were added with 125 mM glycine and transferred to a microfuge
tube containing 100 ml of M buffer, 0.8% NP-40, 1 mM DTT, and
1 mM PMSF; incubated on ice for 15 min; homogenized with
a pestle; and pelleted by centrifugation at 2100g for 5 min at
48C. The supernatant (cytoplasmic extracts) was recovered and
the pellet (chromatin proteins) was resuspended in boiling
SDS-PAGE loading buffer. Proteins were fractionated by SDS-
PAGE and analysed by protein blotting using anti-Hsp10
(rabbit polyclonal, StressGen) at 1 : 2000 dilution. The chemi-
luminescent HRP-conjugated secondary antibodies (anti-rabbit
1 : 50 000 dilution) were used and the reaction developed using
the Super Signal West Femto substrate (Pierce, Milan, Italy)
and acquired with the ChemiDoc XRS imager (Bio-Rad).
3.14. Nucleosome band-shift assay
A total of 146-bp and 251-bp amplified rDNA fragments [39]
were incubated with increasing amounts of recombinant
human and recombinant Drosophila ISWI [40], respectively,
in 10 ml final volume containing 50 mM Tris–HCl (pH 8),
50 mM NaCl, 1 mM MgCl2, 100 mg ml
21 chicken albumin,
0.05% NP-40 and 10% glycerol. The reaction was incubated
for 15 min at 258C and samples were resolved on 1.4% agar-
ose gel in 0.3 Tris–borate–EDTA buffer at 48C for 50 min as
previously reported [39] and detected by EtBr staining.
3.15. Statistical analyses
Data were plotted using MS EXCEL software. Statistical analyses
were performed using GRAPHPADPRISM v. 4 software (GraphPad
Software, San Diego, CA, USA). The statistical methods used
were non-parametric analyses. The significance of the differencesin chaperonins levels between control and CSE treatments was
assessed by the Kruskal–Wallis test, and significance of differ-
ences between different groups was analysed by the Mann–
Whitney test. Values were considered significant when p 0.05.
3.16. Computational studies (in silico analyses)
In order to confirm the variations in Hsp10 subcellular local-
ization on the basis of physical–chemical parameters, in silico
analyses were carried out using online ExPASy Proteomics
Server (http://www.expasy.org). In this site, methods are
found that use various algorithms to determine the character-
istics of primary amino acid sequences such as physical–
chemical features, based for example on electric charges,
hydrophobic moment, number of hydrophobic amino acids,
etc. We used PSORT for prediction of subcellular localization
and of nucleic acid-binding motifs.
4. Results
4.1. In vivo analysis of Hsp10 and Hsp60 levels
and cellular localization
We quantified the levels of Hsp10 and Hsp60 in epithelium
and lamina propria of bronchial mucosa of non-smoker and
smoker subjects with normal lung function to determine if
there was an increase associated with smoking, which is con-
sidered a source of stressors for the airways tissues. The
clinical characteristics of the subjects studied are shown in
the electronic supplementary material, table S1. Hsp10 and
Hsp60 levels did not show quantitative changes in epithelium
or in lamina propria of the bronchial mucosa of smokers com-
pared with non-smokers (figure 1a). Both molecules showed a
cytoplasmic positivity, often with a granular pattern resem-
bling a mitochondrial positivity (figure 1b). Hsp10 was
positive in both groups of subjects, smokers and non-smokers,
and both in epithelial and lamina propria cells. Notably, while
Hsp60 positivity is clearly outside cell nuclei, the Hsp10 pat-
tern suggests a nuclear positivity which may not be fully
explained by a simple superimposition with cytosol.
4.2. 16HBE and HFL-1 cell viability after CSE exposure
We performed a set of in vitro experiments to determine poss-
ible effects on Hsp10 and Hsp60 levels and subcellular
localization caused by exposure to CSE. We first determined
if CSE exposure at various concentrations caused cell death.
HFL-1 and 16HBE cells were incubated for 24 h with CSE
at different percentages (1, 2, 5 and 10%) and, after the incu-
bation, the cell morphology was examined by phase-contrast
microscopy. For both cell lines, morphological features were
maintained after 24 h of treatment (figure 2a). Also, to
assess the effects of CSE exposure on cell viability, we per-
formed viability assays by using MTT. The doses of CSE
used in this study did not produce any detectable decrease
in cell viability in HFL-1 or 16HBE cells (figure 2b).
4.3. Immunolocalization of Hsp10 and Hsp60
in CSE-treated 16HBE and HFL-1 cells
We quantified the levels of Hsp10 and Hsp60 in 16HBE and
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Figure 1. Immunohistochemical detection of Hsp10 and Hsp60 in human
bronchial mucosa. (a) The levels of Hsp10 in epithelium (Ep) and in
lamina propria (Lp) were similar in non-smokers compared with smokers.
Hsp60 was detected only in epithelial cells and its levels were also similar
in non-smokers and smokers. Statistical analyses showed that all of the vari-
ations were not significant with p-values ranging between p ¼ 0.1 and 0.4.
(b) Representative immunohistochemical images. Hsp10 is present in epi-
thelium and lamina propria cells of non-smokers and smokers, whereas
Hsp60 is present only in epithelial cells. Arrowheads, epithelial positivity;
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( p. 0.05; figure 3a). Hsp60 was present in the cytoplasm, often
with the granular aspect typical of mitochondrial localization
(figure 3b). Hsp10 showed not only a wide cytoplasmic, gran-
ular distribution but also an appreciable positivity at the
nuclear level (figure 3b, insets). These data were in agreement
with the in vivo immunohistochemical results obtained with
bronchial mucosa cells as described above, and showed nuclear
localization of Hsp10 in treated and untreated cells. To the best
of our knowledge, positivity for Hsp10 in the nucleus of
airways mucosa cells has never been described before.4.4. Immunogold analysis of Hsp10 and Hsp60 in
untreated 16HBE and HFL-1 cells
To verify the immunohistochemical results showing nuclear
localization of Hsp10 in normal cells with another method,
immunogold analyses were performed on ultrathin sections
of untreated 16HBE and HFL-1 cells. Both 16 HBE and HFL-1
cells showed Hsp10 positivity in the nucleus (figure 4a), in
addition to the typical mitochondrial localization (figure 4a,
insets). By contrast, we did not find nuclear localization for
Hsp60, although both chaperonins were also positive in the
cytosol and, slightly, in the plasma membrane in both cell lines.4.5. Western blotting of whole cell lysates
We performed western blotting to further determine if CSE
stimulation does or does not induce quantitative changes in
Hsp10 and Hsp60 levels; as described above the immuno-
histochemical method did not detect changes (figure 3a).
Total proteins extracted from NT 16HBE and HFL-1 cells
and after 24 h of CSE exposure were used for 1D SDS-
PAGE. Figure 4b shows histograms displaying results of
semi-quantitative densitometry of Hsp10 and Hsp60 levels
in 16HBE and HFL-1 cells after CSE exposure (from 1 to
10%) in comparison with the controls (i.e., cells not treated
with CSE). 16HBE expressed both Hsp10 and Hsp60 in all
the tested conditions. Hsp60 showed increased levels after
24 h of treatment with 10% CSE by comparison with the
untreated controls ( p, 0.01). By contrast, Hsp10 in 16HBE
as well as both molecules in HFL-1 did not show any signifi-
cant difference between treated and NT cells. The observed
difference in the levels of Hsp60 after 24 h of 10% CSE treat-
ment compared with controls is in contrast to the previously
described immunocytochemical data, which did not show a
significant difference. This discrepancy may be attributed to
the higher sensitivity of western blotting as compared with
immunohistochemistry for measuring protein levels. In fact,
the two methods are complementary with immunohisto-
chemistry having resolution power to map the topography of
antigens in subcellular compartments and tissue types,
whereas western blotting is advantageous to directly identify
immunologically and quantify protein bands. Except for this,
the other results from western blotting were in agreement
with immunocytochemistry.
4.6. Two-dimensional SDS-PAGE on total protein
extracts
In order to determine if qualitative variations in the Hsp10 and
Hsp60 molecules did occur after CSE exposure, 2D SDS-PAGE
analyses were performed on 100 mg of total protein extracts.
To perform this set of experiments we used two sources of
materials for protein extraction, NT cells as control and cells
exposed to 5% CSE for 24 h. The choice of this CSE concentration
was based on 1D western blot results: we used the highest con-
centration that did not determine changes in the Hsp10 and
Hsp60 levels. Western blots and resulting spots were analysed
using gel matching, with reference maps in our laboratory data-
base, as explained in Material and Methods. Figure 5 shows the
results of 2D-IPG western blot of the Hsp60 isoforms in the HFL-
1 cell line under control condition and after 24 h of treatment
with 5% of CSE. Control cells showed four Hsp60 isoforms
with the same relative molecular weight (Mr ¼ 57 500) but dis-
tinct pIs, 5.09, 5.14, 5.18 and 5.24 (figure 5a). After 5% CSE
exposure, HFL-1 showed only the absence of the Hsp60 5.09 iso-
form (figure 5b). More differences were instead found when
analysing the results of Hsp10 isoforms. Control conditions
(figure 5c) showed three different isoforms of Hsp10: one, the
more highly expressed and basic isoform (likely to be the typical
canonical Hsp10), had an apparent Mr of 10 800 and pI of 8.7
(relative to the most expressed isoform); the other two isoforms
had a Mr of 10 600, with pI 8.3, and Mr 11 000, with pI 7.5. Con-
siderable modifications were visible following CSE treatment.
On the one hand, the canonical isoform showed Mr and pI
shifts (Mr ¼ 11 500; pI¼ 8.9), on the other hand, the two acid
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Figure 2. Morphologic and cell viability analyses after cell exposure to CSE. (a) Phase-contrast microscopy images of 16HBE and HFL-1 cell lines: non-treated controls
(NT) and after 24 h of treatment with CSE at various concentrations from 1 to 10%. No morphologic changes after CSE treatment are apparent, indicating that CSE,
at the concentrations used in this work, had no cytotoxic effect. (b) Cell viability measured by the MTT test also did not show any cytotoxic effect of CSE, with























































Figure 3. Immunocytochemistry for Hsp10 and Hsp60. (a) Levels of Hsp10
and Hsp60 in 16HBE and HFL-1 cells before (NT) and after (10%) incubation
with CSE at 10%. No statistically significant differences were found between
the groups ( p-values ranging between 0.48 and 0.68). (b) Representative
microphotographs showing immunolocalization by immunohistochemistry of
Hsp10 and Hsp60 in 16HBE and HFL-1 cells. The insets indicate nuclear
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Hence, CSE exposure in bronchial cell lines induced qualitative
modifications in the two chaperonins, particularly in Hsp10.
4.7. Mass spectrometry analyses
In order to further verify the identity of the three Hsp10 iso-
forms described in the preceding subsection, we carried out
mass spectrometry analyses on spots cut from Coomassie
blue-stained 2D gels. After trypsin digestion and HPLC
analyses, identification of amino acid sequences of the spots
was obtained by ESI-MS (electrospray ionization-mass spec-
trometry). Recognized peptide fragments possessed amino
acid sequences comprising the primary amino acid sequence
of Hsp10 (figure 5e), confirming the identity of the basic spot
as canonical Hsp10. Also, the tryptic digest of the other two
more acidic spots excised from the gels showed the presence
of peptide fragments belonging to the amino acid sequence
of Hsp10, therefore identifying also these two spots as acid iso-
forms of Hsp10. The peptide fragment recognized in all the
three spots was 41VLQATVVAVGSGSK54. The complete list
of peptides identified by MS experiments is reported in the
electronic supplementary material, table S2. These findings
confirm the 2D western blotting results and support the idea
that CSE treatment might be responsible for the decrease or dis-
appearance of Hsp10 acid isoforms. Moreover, CSE treatment
may have caused post-translational modifications responsible
for the shifts in Mr and pI of the canonical isoform of Hsp10.
4.8. Western blotting analysis for Hsp10 in subcellular
fractions of 16HBE and HFL-1 cells
In order to verify Hsp10 levels in the cytoplasm and in the
nuclear fraction, we performed western blotting analyses on
NT
% CSE % CSE
1 2 5 10 NT 1 2 5 10
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Figure 4. Localization of Hsp10 by electron microscopy and the immunogold technique and western blotting analyses of Hsp10 and Hsp60 in cell lines. (a) Immu-
nogold for Hsp10 on 16HBE and HFL-1 cells, showing its nuclear localization in addition to its typical presence in mitochondria (insets). Arrows indicate some of the
Hsp10 positivity in the nucleus and in mitochondria. (b) Western blotting analyses of total protein extracts from 16HBE and HFL-1 cell lines after treatment with CSE
at various concentrations from 1 to 10%, for 24 h, in comparison with NT cells. Statistical analysis was performed using the Mann–Whitney test. Data are rep-
resented as mean (+s.e.m.) of three replicate experiments. Only Hsp60 showed a significant increase after 24 h of treatment of 16HBE cells at 10% CSE
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control and 24 h-CSE-treated 16HBE and HFL-1 cells. In both
cells, Hsp10 was found in all tested conditions, not only in the
cytoplasmic but also in the nuclear fraction (figure 6). Cyto-
plasmic contamination of the nuclear fraction was searched by
assessing lactate dehydrogenase, and the results indicated no
contamination. Interestingly, the statistical analyses showed an
increase in Hsp10 levels in the nucleus after 5%, and 10% CSE
stimulation in 16HBE and after 2, 5 and 10% CSE stimulation
in HFL-1. By contrast, cytosolic Hsp10 was reduced after 2%
and 10% CSE stimulation in HFL-1 but did not change in
16HBE. These data suggest a subcellular redistribution of
Hsp10, at least in HFL-1 cells, after CSE exposure, i.e. in these
cells Hsp10 seems to migrate from cytosol to nucleus.4.9. Western blotting analyses of Hsp10 on chromatin
proteins and gel retardation assays
To better understand the significance of Hsp10 localization in the
nucleus in normal conditions, we performed a 1D SDS-PAGE on
supernatant (SN) and chromatin pellet (P) from not-fixed and
fixed 16HBE and HFL-1 cells in control condition (not exposed
to CSE). Fixation was performed using formaldehyde.
Figure 7a,b shows the results of the western blotting for Hsp10.
Both cell lines that were not fixed with formaldehyde showed
the presence of Hsp10 in the supernatant only (SN not-fixed),
but the chaperonin was not present in not-fixed chromatin (Pnot-fixed). The cells that were fixed (both cell lines), showed
the absence of Hsp10 in the supernatant (S fixed) and its pres-
ence in the chromatin faction (P fixed). These results show that
Hsp10 in the nucleus is close to the chromatin.
In order to determine if Hsp10 would directly interact with
DNA, gel retardation assays (band-shift assays) were carried
out on 0.5 nmol of 146- and 251-bp rDNA fragments (50 and
80 ng, respectively), using increasing amounts (0, 4, 8, 16, and
32 nmol) of recombinant human Hsp10 and, as control, recom-
binant Drosophila ISWI. No band shift was observed with
human recombinant Hsp10, neither on 146-bp (figure 7c) nor
on 251-bp (figure 7d) rDNA fragments, in contrast to results
with Drosophila recombinant ISWI. These findings indicate
that Hsp10 does not directly interact with DNA, but is bound
to chromatin, suggesting that the chaperonin interacts with
nuclear proteins whose identity remains to be clarified.4.10. In silico investigations and computational analyses
for protein sorting
In order to find structural features that would explain the results
obtained in vitro, we performed in silico analyses, using avail-
able tools to characterize the Hsp10 molecule. ExPASy Server
tools were used for detecting physical–chemical features. All
the algorithms based their analyses on primary amino acid
sequences, charge distribution and other molecular parameters,




















































































Figure 5. 2D SDS-PAGE and mass spectrometry analyses. 2D SDS-PAGE of Hsp60 (a,b) and Hsp10 (c,d ) before (a,c ) and after (b,d ) treatment of the cells with CSE
5% for 24 h. Both Hsp10 and Hsp60 showed changes in Mr and pI after treatment. (e) Proteomic and mass spectrometry analyses confirmed the identity of the three
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Figure 6. Identification of Hsp10 in subcellular fractions by western blotting.
Hsp10 was detected in the cytoplasmic fraction (a,c) of 16HBE (a) and HFL-1
(c) cells treated with various concentrations of CSE (from 1 to 10%, as indicated).
Likewise, Hsp10 was detected in the nuclear fraction of both cells lines (b,d ) and
its levels were significantly higher after treatment with 2% or higher concen-
trations of CSE by comparison with NT cells in HFL-1 ( p, 0.05), and 5% or
higher in 16HBE ( p, 0.05), indicating that this treatment induced an increase
in Hsp10 in the nucleus. A significant ( p, 0.05) decrease in Hsp10 was
observed in the cytoplasm of HFL-1 cells after treatment with 2 and 10%
CSE. b-Actin and lamin were used as cytoplasmic and nuclear internal controls,
respectively. Possible contamination of nuclear preparations with cytoplasm was
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logical in vivo environment. By using PSORT II, prediction of
protein subcellular localization was investigated for Hsp10.
PSORT II uses a series of methods taking into account several
physical–chemical parameters, for instance number of basic
amino acids, hydrophilic state, hydrophobic moment and
other features. Among these methods, the k-Nearest Neighbors
is an algorithm that evaluates the probability of sub-localization
in different cell compartments. Table 1 shows the results, pre-
dicting a predominant cytoplasmic localization (56.5%) for
Hsp10, which is remarkable considering that Hsp10 is classi-
cally thought to be a mitochondrial protein. The nucleus was
predicted as second subcellular localization (17.4%), which sup-
ports our experimental results, indicating presence of Hsp10 in
the nucleus.4.11. Prediction of localization signals and nucleic
acid-binding motifs
In order to find possible explanations for the presence of
Hsp10 in the nucleus, PSORT II software was used to predictthe presence of an amino acid sequence that could serve as a
DNA- or RNA-binding motif. Data in the electronic sup-
plementary material, table S3 show that Hsp10 does not
possess typical DNA- or RNA-binding motifs. This result
indicates that Hsp10 in the nucleus does not bind DNA but
a chromatin protein, as indicated by the experimental results
described above.5. Discussion
Hsp10 and Hsp60 have for a long time been considered typi-
cal intramitochondrial molecules devoted to assisting protein
folding inside the organelle. However, there is now evidence
that the Hsp10 and Hsp60 are also localized in other cell com-
partments such as cytosol, granules and plasma membrane
[3]. The subcellular localization of Hsp10 was investigated
in rat tissues by the immunogold technique. In all examined
anatomical regions, Hsp10 was present in mitochondria, but
a strong and specific Hsp10 positivity was also found in sev-
eral extra-mitochondrial compartments in various structures.
These included zymogenic granules in pancreatic acinar cells,
growth hormone granules in anterior pituitary and pancreatic
polypeptide granules in pancreatic islet cells [41]. It was pro-
posed that Hsp10 may reach the bloodstream via these
secretory granules. It was also reported that Hsp10 labelling
in these extra-mitochondrial compartments was at least com-
parable with, if not higher than, that seen in mitochondria. By
contrast, the labelling in other cell compartments such as the
nucleus was generally weak, near background levels. These
observations for Hsp10 were similar to those that had been
reported earlier for Hsp60 [42].
The role of Hsp10 residing in the cytoplasm is not yet well
understood. It was demonstrated that an interaction of Hsp10
and Hsp60 with procaspase-3 occurs in the mitochondria of
Jurkat cells, and that the disruption of this complex is
accompanied by the release of active caspase fragments from
the mitochondrial intermembrane space, which is followed
by progression to cell death [43]. It was also demonstrated
that the increase in Hsp10 levels in cardiac myocytes protects
mitochondrial function, thus exerting an anti-apoptotic effect
during ischaemia/reoxygenation [16]. Hsp10 and Hsp60
have a similar distribution and higher than normal levels in
cells before and after stress and during pathogenesis of a
number of diseases, including cancer [44] and inflammatory
diseases [45]. Furthermore, Hsp10 has also been found
increased in some precursors of normal human bone-marrow
cells and it disappeared during lineage maturation, while
Hsp60 did not show changes in levels during bone marrow
cell differentiation [46]. These data support the notion that
intracellular Hsp10 has roles, probably independent of
Hsp60, different from its canonical function as co-chaperone
for Hsp60 in protein folding inside mitochondria.
To the best of our knowledge, this is the first report of
Hsp10 localization in nucleus of human bronchial cells. The
work reported here shows that (i) in specimens from subjects
with normal respiratory function, either smokers or non-smo-
kers, Hsp10, in contrast to Hsp60, was localized not only in the
cytoplasm but also in nuclei of epithelial and lamina propria
cells of bronchial mucosa in vivo. The Hsp10 levels in the
nucleus was the same in the two groups of subjects.
(ii) Human bronchial epithelial cells and lung fibroblasts,
in vitro, showed Hsp10 but not Hsp60 positivity in the nucleus,
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HFL-1
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Figure 7. Search for Hsp10 interactors in the nucleus. 1D western blotting analyses of Hsp10 on chromatin proteins and gel retardation assays (band shift) on 16HBE (a)
and HFL-1 (b) cells. SN not-fixed, supernatant fraction not-fixed with formaldehyde; P not-fixed, chromatin fraction not-fixed with formaldehyde; S fixed, supernatant
fraction fixed with formaldehyde; P fixed, chromatin fraction fixed with formaldehyde. Gel retardation assays were carried out on 0.5 nmol of 146 bp (c) and 251 bp (d )
rDNA fragments, using increasing amounts (0, 4, 8, 16 and 32 nmol) of recombinant human Hsp10 and recombinant Drosophila ISWI used as control.
Table 1. Predicted subcellular localization for Hsp10. k-Nearest Neighbors
(PSORT II) results, showing the prediction of the possible subcellular
localization of Hsp10.










on November 11, 2014Downloaded from before and after CSE exposure; (iii) CSE did not cause an
appreciable overall increase in levels of Hsp10 in either cell
line; (iv) CSE exposure determined in both cells lines qualitat-
ive changes in Hsp10, as indicated by Mr and pI shifts. In
addition, the less expressed isoforms of Hsp10 were undetect-
able after CSE exposure; (v) Hsp10 nuclear levels increased
after CSE exposure in HFL-1, suggesting a migration of this
protein from cytosol to nucleus in response to the exogenous
stimulus; (vi) Hsp10 in the nucleus did not bind DNA but it
bound one or more nuclear proteins; and (vii) bioinformatics
predicted that Hsp10 can occur in the nucleus but it does
not have structural features, i.e. motifs, for DNA binding.
In a previous paper, we discussed three molecules, EPF,
extracellular Hsp10, and intracellular Hsp10, all of which had
been described independently, at different times, with diversefunctions [1]. These three molecules are in fact variants of the
product of the same gene. How these variants originate and
what are their distinctive structural features, if any, is still
unclear, but investigations in this area should provide data
useful to understand the various functions of Hsp10 and the
mechanisms pertaining to its various localizations.
The results from the proteomics experiments provided
novel insights on the existence of different isoforms of
human Hsp10, which are differently regulated by a stressor
such as CSE. Our data demonstrated that in normal cell
lines three different isoforms of Hsp10 are detectable (cen-
tered at pI of 7.5, 8.3 and 8.7), with the most basic one
being the most expressed (or canonical) form. A database
search in Expasy and related databases (not shown) showed
that the only experimental evidence of human Hsp10 (Uni-
ProtKB accession number P61604) in a 2D database refers
to a spot at pI ¼ 8.9, identified by researchers of the Univer-
sity College Dublin (http://proteomics-portal.ucd.ie:8082/
cgi-bin/2d/2d.cgi?P61604) in human brain and heart
samples run on 6–11 IPG strips. However, the reported Mr
of this molecule is between 8280 and 8900 Da. Given a theor-
etical pI of 8.9 and a theoretical Mr of 10 800 Da, it seems
unclear which modification in the mature protein may have
caused this shift. No data are available, to the best of our
knowledge, on the existence of other isoforms of Hsp10 at
more acidic pI values, such as those we demonstrated in the
two cell lines we investigated by means of both 2D western
blotting and tandem mass spectrometry. We can hypothesize
that these isoforms are derived by post-translational modifica-





on November 11, 2014Downloaded from searches showed that one phosphorylation site has been
demonstrated at threonine 79 [47], and another four sites
are predicted to exist at serine and tyrosine residues (NetPhos
2.0 analysis, not shown). Phosphorylation, albeit leading to
nearly undetectable Mr changes at the protein level, may
have a dramatic effect on pI: for example, Scansite analysis
of Hsp10 showed that a single phosphorylation event
may result in an isoform with a theoretical pI of 7.38
(http://scansite.mit.edu). Moreover, multiple acetylation
sites have been demonstrated at lysine and alanine residues
in the same protein sequence, apart from the known N-term-
inal acetylation (at alanine). All of these modifications may
have relevant effects on the pI of the modified protein, as
well as on its molecular weight. Impairment of deacetyla-
tion enzymes, which may add further complexity to the
isoform pattern of Hsp10, has been linked to cigarette
smoke stimulus in lung cells, as demonstrated for histone
deacetylases (HDACs) and sirtuins, whose impairment has
been correlated to the inflammatory stimulus arising from
smoke challenge [48–52].
The demonstration of the exact modifications occurring to
the more acidic isoforms of Hsp10 and the identification of
the cellular modifying enzymes is beyond the scope of the
present paper, but it is currently under active investigation
in our laboratory.
Data reported here indicate that in human cells of the res-
piratory mucosa there are at least three different intracellular
locales for Hsp10: mitochondrial, nuclear, and cytosolic. It is
likely that in these three locations there occur as many variants
of Hsp10 with distinct roles, perhaps all related to chaperoning
functions but pertaining to distinct substrates and/or protein
quality control pathways. The balance between these forms is
probably well regulated in the cell but this is still a matter for
further research. One can hypothesize that the induction of
Hsp10 gene expression, or overexpression, by a variety of stres-
sors results in a redistribution of the chaperonin whose final
destination and functions depends on the gene-inducing
cause and mechanism. Thus, Hsp10 can enter into the mito-
chondria to collaborate with Hsp60 in protein folding, or
transfer to secretory granules (either for chaperoning proteins
in them or for escaping out of the cells and reaching the blood-
stream), or translocate to the nucleus.
Hsp10 could translocate into the nucleus by itself via an
as yet to be discovered mechanism, or translocation could
take place by association with another protein equipped for
that task, thus enabling the chaperonin lacking a nuclearlocalization signal to gain the intranuclear space. In the
latter location, Hsp10 may play roles such those expected
from intranuclear molecules, e.g. participation in cell prolifer-
ation, differentiation and death.
The electronic supplementary material, table S4 shows the
results of an in silico analysis to search for known interactors of
Hsp10 with clear nuclear localization. Twenty-two unique mol-
ecules have been discovered using both Biogrid and IntAct
databases. Of note, some of these molecules, are known tran-
scription factors, or molecules involved in the control of the
cell cycle, or even other chaperone molecules, such as mortalin.
In addition, other interactors of Hsp10 have been shown to have
direct and indirect roles in chromatin remodelling and transcrip-
tional control. For example, CBX3 recognizes and binds histone
H3 tails methylated at ‘Lys-9’. This may lead to epigenetic
repression or, as recently shown, also to differential maturation
of RNAs (co-transcriptional alternative splicing) [53]. Also, the
histone-binding protein RBBP7 is a component of several
complexes that regulate chromatin metabolism. Another rel-
evant molecule is ATF2: it is a transcriptional activator that
regulates the transcription of genes such as those involved in
anti-apoptosis, cell growth and DNA damage response. In par-
ticular, recent data linked ATF2 downregulation to an increased
apoptosis after oxidative stress stimuli [54].
Finally, variations in the levels of Hsp10 beyond the
normal range for each localization may have a pathogenic
significance. For instance, the increase, or decrease, of
Hsp10 in cancer could be involved in regulation of apoptosis
of tumour or pre-tumoural dysplastic cells.
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